Pulmonary Hypertension Clinical Trial
— KEPAHOfficial title:
Ketone Administration in Patients With Pulmonary Hypertension - Effects on Hemodynamics
Verified date | July 2020 |
Source | University of Aarhus |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
In the present study, patients with idiopathic pulmonary hypertension (IPAH) and chronic thromboembolic pulmonary hypertenion will be investigated in a randomized cross-over design with ketone infusions and placebo. Invasive and non-invasive hemodynamics will be evaluated
Status | Completed |
Enrollment | 20 |
Est. completion date | November 29, 2021 |
Est. primary completion date | May 1, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Persistent pulmonary hypertension (defined as PVR > 3 WU, pulmonary capillary wedge pressure (PCWP) < 15 mmHG, mean pulmonary arterial pressure (mPAP) =25 mmHg) on the most resent right heart catheterization. - Preserved left ventricular ejection fraction (<50%) on most recent echocardiography - Able to give informed consent Exclusion Criteria: - Other Significant pulmonary, mitral or aortic valve disease - Other disease or treatment making subject unsuitable for study participation |
Country | Name | City | State |
---|---|---|---|
Denmark | Dept. of cardiology, Aarhus University hospital Skejby, | Aarhus | Region Midjylland |
Lead Sponsor | Collaborator |
---|---|
University of Aarhus | Danish Heart Foundation |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Cardiac output (L/min | Measured by Swan-Ganz monitoring | changes during the infusion for 2.5 hours compared to 2.5 hours of Saline infusion | |
Secondary | mixed venous saturation (%) | Hemodynamics - Swan Ganz monitoring | changes during the infusion for 2.5 hours compared to 2.5 hours of Saline infusion | |
Secondary | systemic blood pressure (mmHg) | Hemodynamics - non-invasive blood pressure measurement | changes during the infusion for 2.5 hours compared to 2.5 hours of Saline infusion | |
Secondary | pulmonary capillary pressure (mmHg) | Hemodynamics - Swan Ganz monitoring | changes during the infusion for 2.5 hours compared to 2.5 hours of Saline infusion | |
Secondary | Pulmonary pressure (mmHg) | Hemodynamics - Swan Ganz monitoring | changes during the infusion for 2.5 hours compared to 2.5 hours of Saline infusion | |
Secondary | TAPSE (mm) | Echocardiography | changes during the infusion for 2.5 hours compared to 2.5 hours of Saline infusion | |
Secondary | RV strain (%) | Echocardiography | changes during the infusion for 2.5 hours compared to 2.5 hours of Saline infusion | |
Secondary | LV strain (%) | Echocardiography | changes during the infusion for 2.5 hours compared to 2.5 hours of Saline infusion | |
Secondary | systolic tricuspid plane velocity (cm/sec) | Echocardiography | changes during the infusion for 2.5 hours compared to 2.5 hours of Saline infusion | |
Secondary | Left ventricular ejection fraction (%) | Echocardiography | changes during the infusion for 2.5 hours compared to 2.5 hours of Saline infusion | |
Secondary | Changes in Prostaglandines (pmol/L) | Blood samples | changes during the infusion for 2.5 hours compared to 2.5 hours of Saline infusion | |
Secondary | pH | Blood samples | changes during the infusion for 2.5 hours compared to 2.5 hours of Saline infusion | |
Secondary | sodium (mM) | Blood samples | changes during the infusion for 2.5 hours compared to 2.5 hours of Saline infusion | |
Secondary | potassium (mM) | Blood samples | changes during the infusion for 2.5 hours compared to 2.5 hours of Saline infusion | |
Secondary | lactate (mM) | Blood samples | changes during the infusion for 2.5 hours compared to 2.5 hours of Saline infusion |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT01950585 -
Hydroxyurea in Pulmonary Arterial Hypertension
|
Early Phase 1 | |
Completed |
NCT00527163 -
Role of Nitric Oxide in Malaria
|
||
Completed |
NCT03649932 -
Enteral L Citrulline Supplementation in Preterm Infants - Safety, Efficacy and Dosing
|
Phase 1 | |
Recruiting |
NCT04554160 -
Arrhythmias in Pulmonary Hypertension Assessed by Continuous Long-term Cardiac Monitoring
|
||
Enrolling by invitation |
NCT03683186 -
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
|
Phase 3 | |
Completed |
NCT01894035 -
Non-interventional Multi-center Study on Patients Under Routine Treatment of Pulmonary Arterial Hypertension (PAH) With Inhaled Iloprost Using I-Neb as a Device for Inhalation
|
||
Not yet recruiting |
NCT04083729 -
Persistent Pulmonary Hypertension After Percutaneous Mitral Commissurotomy
|
N/A | |
Terminated |
NCT02243111 -
Detecting Pulmonary Arterial Hypertension (PAH) in Patients With Systemic Sclerosis (SSc) by Ultrasound
|
N/A | |
Completed |
NCT02216279 -
Phase-II Study of the Use of PulmoBind for Molecular Imaging of Pulmonary Hypertension
|
Phase 2 | |
Terminated |
NCT02246348 -
Evaluating Lung Doppler Signals in Patients With Systemic Sclerosis (SSc)
|
N/A | |
Completed |
NCT02821156 -
Study on the Use of Inhaled NO (iNO)
|
N/A | |
Recruiting |
NCT01913847 -
Safety and Efficacy Study of HGP1207 in Patients With Pulmonary Hypertension
|
Phase 3 | |
Completed |
NCT01615484 -
Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability
|
N/A | |
Completed |
NCT06240871 -
Contrast Enhanced PA Pressure Measurements
|
||
Completed |
NCT02377934 -
Evaluation of Radiation Induced Pulmonary Hypertension Using MRI in Stage III NSCLC Patients Treated With Chemoradiotherapy. A Pilot Study
|
||
Recruiting |
NCT01091012 -
Effectiveness of the Vasodilator Test With Revatio, Made in Patients With Acute Pulmonary Hypertension
|
Phase 3 | |
Completed |
NCT02275793 -
The Regulation of Pulmonary Vascular Resistance in Patients With Heart Failure
|
||
Completed |
NCT01484899 -
Smoking: a Risk Factor for Pulmonary Arterial Hypertension?
|
N/A | |
Completed |
NCT01463514 -
Noninvasive Determination of Cerebral Tissue Oxygenation in Pulmonary Hypertension
|
N/A | |
Completed |
NCT00739375 -
The Effect of Blood Flow in the Maturing Arteriovenous Access for Hemodialysis on the Development of Pulmonary Hypertension.
|
Phase 1 |